Vascular Smooth Muscle Function Professors and Supervisors | ApplySharif

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۱۶-۳۰ از ۶۰۴ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Gary K. Owensمشاهده پروفایل

استاد

University of VirginiaUnited States

Dr. Gary K. Owens is a Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia , with a secondary appointment in the Department of Medicine, Division of Cardiology. He serves as Director of the Robert M. Berne Cardiovascular Research Center and leads groundbreaking research on vascular smooth muscle cell (SMC) dynamics in atherosclerosis. His work challenges conventional paradigms about SMC roles in plaque stability and thromboembolic events. Primary Affiliation: University of Virginia Key Titles: Robert M. Beirne Professor of Cardiovascular Research, Professor, Director of CVRC Research Themes include: Cardiovascular Biology Atherosclerosis Pathogenesis Smooth Muscle Cell Plasticity Epigenetic Regulation Inflammatory Signaling Tumor Metastasis Mechanisms Publication Trends (2015–2024) reveal expertise in Nature Medicine and Circulation studies, focusing on SMC gene regulation (Klf4/Oct4), plaque stability, and cross-talk between vascular cells and tumors. His work demonstrates that SMCs account for >80% of advanced lesion cells and that Klf4 inhibition reduces metastasis by >70%. Lab Leadership includes mentoring PhD students Anita Salamon and Victoria Milosek , alongside senior scientists and postdocs. Collaborations span with Dr. Gwen Randolph (Washington University) and Dr. Rosey Kaplan (NIH) on IL1β signaling and metastasis.

پروفایل رسمی دانشگاه

Gregory Dickمشاهده پروفایل

استاد پژوهشی

University of North Texas Health Science CenterUnited States

Gregory Dick, PhD, is a Research Professor in the Department of Physiology & Anatomy at the University of North Texas Health Science Center's College of Biomedical and Translational Sciences. His research focuses on ion channel regulation in coronary arteries, particularly how potassium channels control vascular tone under normal and pathological conditions (e.g., obesity, diabetes). He has led multiple NIH-funded projects exploring coronary vascular dysfunction and metabolic signaling. Education: Bachelor of Science in Physiology, Oklahoma State University Doctor of Philosophy in Physiology, University of Missouri Research Interests: Electro-metabolic signaling in coronary vasodilation Role of K+ channels in coronary blood flow regulation Impact of metabolic syndrome and obesity on cardiovascular health Vascular smooth muscle plasticity in disease states Key Projects (2024–2026): Role of potassium as a coronary metabolic vasodilator (Principal Investigator) Disentangling the Mechanisms of Coronary Dysfunction (Co-Investigator) Grants & Funding: NIH R01 Grant: Mineralocorticoid Receptor-Dependent Coronary Vascular Dysfunction in Obesity Multiple collaborative grants with University of Michigan and University of Missouri Collaborations: Active partnerships with institutions studying coronary autoregulation, metabolic syndrome, and swine models of cardiovascular disease.

پروفایل رسمی دانشگاه

Andrew Braunمشاهده پروفایل

استاد

University of CalgaryCanada

Andrew Braun is a Professor at the University of Calgary, affiliated with the Libin, Hotchkiss Brain Institute, and Snyder Institute. His research focuses on vascular physiology, particularly the role of potassium channels in regulating blood flow and pressure, with applications in diabetes and neurodegenerative diseases. He utilizes advanced techniques like patch clamping and arterial pressure myography. His work explores KCa channels , nitric oxide signaling , and calcium dynamics in vascular cells, aiming to develop novel therapies for endothelial dysfunction. He investigates how these channels affect myogenic tone , vasodilation , and coronary circulation in diseased states such as Type 2 Diabetes and Alzheimer's. The 15 most recent publications highlight his focus on pharmacological targeting of KCa channels to treat vascular complications in diabetes, aging, and atherosclerosis. Key subfields include platelet aggregation , genetic mutations in IP3 receptors , glycation effects on vascular function , and sex-dependent cerebrovascular defects . Contact information: Email abraun@ucalgary.ca. Administrative Assistant: Theresea Connolly (tconnoll@ucalgary.ca, 403-220-3018).

پروفایل رسمی دانشگاه

Xi-Long Zhengمشاهده پروفایل

استاد

University of CalgaryCanada

Xi-Long Zheng is a tenured Professor in the Department of Biochemistry and Molecular Biology and Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He holds additional appointments as a Member of the Libin Cardiovascular Institute and Associate Member of both the Snyder Institute for Chronic Diseases and Arnie Charbonneau Cancer Institute. His research focuses on vascular smooth muscle biology and its role in cardiovascular diseases. Doctor of Medicine, Hunan Medical University (1986) M.S. in Pharmacology, Hunan Medical University (1989) Doctor of Philosophy in Pharmacology, University of Calgary (1997) Dr. Zheng's research centers on vascular smooth muscle cell differentiation, proliferation, and phenotypic switching in vascular diseases. His laboratory investigates mechanisms of vascular smooth muscle dedifferentiation in atherosclerosis, abdominal aortic aneurysms, and vascular stiffness. Current work explores ferroptosis, epigenetic regulation (particularly BRD4), and PCSK9 functions in vascular pathologies. His studies integrate molecular, cellular, and in vivo approaches to identify novel therapeutic targets for cardiovascular diseases. Analysis of his recent publications reveals strong emphasis on cell death mechanisms (ferroptosis, cuproptosis), epigenetic regulation, lipid metabolism, and immune-vascular interactions in atherosclerosis. His work demonstrates increasing focus on translational applications targeting vascular smooth muscle phenotypic switching and plaque stability. Alberta Innovates ‒ Health Solutions Senior Scholar Award (2008-2015) Heart & Stroke Foundation New Investigator Award (2001-2006) CIHR/Hypertension Society Scholarship Award (2001-2004) Heart & Stroke Foundation Fellowship Award (1999-2001) AHFMR Independent Investigator Award (2008) Dr. Zheng serves on grant panels for Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada. He is an editorial board member for Biochemical Journal and other scholarly publications. His laboratory receives funding from CIHR and NSERC for projects including smooth muscle PCSK9 in abdominal aortic aneurysm pathogenesis, smooth muscle autophagy in vascular aging, and epigenetic regulation of smooth muscle plasticity. The Zheng Lab investigates vascular smooth muscle functions across multiple organ systems including blood vessels, gastrointestinal tract, bladder, and uterus. His research has established critical mechanisms in vascular smooth muscle differentiation and cell cycle regulation, contributing over 100 peer-reviewed publications in high-impact journals including PNAS, ATVB, Diabetologia, JBC, and Hypertension.

پروفایل رسمی دانشگاه

John Eberthمشاهده پروفایل

دانشیار

Drexel UniversityUnited States

Dr. John F. Eberth is an Associate Professor at Drexel University's School of Biomedical Engineering, Science and Health Systems. As a cardiovascular engineer with expertise in mechanical controls, continuum biomechanics, and hydrogel-based extracellular matrix mimetics, he leads the Applied Biomechanics and Mechanobiology Lab (ABML) to investigate vascular behavior under mechanical stimuli. PhD in Biomedical Engineering from Texas A&M University (2008) MS in Mechanical Engineering from Clemson University (2004) BS in Mechanical Engineering from Clarkson University (2001) His research focuses on vascular pathology and mechanobiology, including: Aortopathy and aneurysm mechanics Endothelial dysfunction and arterial stiffening Hydrogel-based vascular grafts Calcification chelation therapy Coronary artery disease Perfusion tissue culture Recent publications demonstrate expertise in vascular imaging techniques, mechanical modeling, and therapeutic interventions. Key themes include drug-coated balloon development, collagen fiber mechanics, and bioreactor systems for vascular conditioning.

پروفایل رسمی دانشگاه

Mansoureh Eghbaliمشاهده پروفایل

استاد

University of California, Los AngelesUnited States

Pulmonary Hypertension
Myocardial Ischemia-Reperfusion Injury
Sex Differences in Cardiovascular Disease
+۳ مورد دیگر

Mansoureh Eghbali, PhD, is a Professor in the Department of Anesthesiology at the David Geffen School of Medicine, University of California, Los Angeles. Her research program investigates molecular mechanisms of cardiovascular and pulmonary diseases with emphasis on sex-specific pathophysiology. She leads an active NIH-funded laboratory focused on pulmonary hypertension, myocardial ischemia-reperfusion injury, and the role of RNA-binding proteins in vascular remodeling. Her research integrates multiomics approaches to explore: Sex chromosome influences (Y-gene Uty) in pulmonary vascular protection MicroRNA regulation of cardiac fibrosis and calcification (e.g., miR-129-5p/Asporin axis) Gut-heart-lung interactions in diet-induced pulmonary hypertension Endothelial subpopulations (TM4SF1+) in disease progression Analysis of her recent publications reveals strong emphasis on: Integrative multiomics in vascular diseases Sex differences in drug responses Novel therapeutic targeting of RNA-binding proteins Cross-organ communication in cardiopulmonary pathologies She directs multiple NIH grants including: R01HL159865: Role of Chromosome Y gene, Uty (2021-2025) R01HL147586: Role of miR125 in pulmonary hypertension (2019-2023) R01HL129051: Role of miR193 in oxidized lipid-induced PH (2016-2021) R01HL131182: Epigenetic regulation by X chromosome (2016-2021)

پروفایل رسمی دانشگاه

Enric Espluguesمشاهده پروفایل

عضو هیئت علمی

Yale UniversityUnited States

Enric Esplugues is a Research Scientist in the Department of Immunobiology at Yale School of Medicine. He previously held an Assistant Professor position at the Icahn School of Medicine at Mount Sinai and was an Associate Research Scientist at Yale. His research focuses on immunological mechanisms in autoimmune diseases, metabolic inflammation, and cancer immunity. PhD, University of Barcelona (2003) Postdoctoral Training, Yale School of Medicine (2005–2008) Dr. Esplugues' research spans immunology and metabolism, with a focus on T cell biology, particularly TH17 and regulatory T cells, and their roles in autoimmunity, atherosclerosis, and cancer. His work investigates how immune cells interact with metabolic pathways in diseases like obesity-induced hepatocellular carcinoma and hypercholesterolemia-driven vascular remodeling. He also studies viral immune evasion mechanisms, including SARS-CoV-2. His recent publications (2023–2025) emphasize the interplay between lipid metabolism and immune responses, particularly in vascular and tumor microenvironments. Key themes include LXR signaling in smooth muscle cells, ferroptosis in cancer, and endothelial triglyceride metabolism. Earlier work (2017–2020) centered on TH17 cell plasticity, tissue-resident memory T cells, and microbiota-immune interactions in cancer and autoimmunity. Notable scientific awards include: CCFA Senior Award (2014) Ramon Margalef Award (2005) Dr. Esplugues has collaborated extensively with researchers such as Carlos Fernández-Hernando, Yajaira Suárez, and Richard Flavell. While no formal students are listed, his role as a research scientist and former assistant professor implies mentorship of trainees. He leads a research laboratory at Yale, focusing on immune-metabolic interactions in disease.

پروفایل رسمی دانشگاه

Lisa A. Cassisمشاهده پروفایل

استاد

University of KentuckyUnited States

Lisa A. Cassis serves as Vice President of Research and Professor of Pharmacology and Nutritional Sciences at the University of Kentucky. She holds multiple leadership positions including Co-Director of the Division of Nutritional Sciences and Graduate Faculty in Nutritional Sciences. Dr. Cassis is affiliated with several research centers including the Saha Cardiovascular Research Center, Saha Aortic Center, and serves as an MD/PhD Program Mentor. Dr. Cassis's research program has focused for over three decades on the renin-angiotensin system (RAS) in metabolic and cardiovascular diseases. Her laboratory made the seminal discovery in 1988 that adipocytes express high levels of angiotensinogen, establishing the concept of an adipocyte RAS. In 1999, in collaboration with Dr. Alan Daugherty, her team demonstrated that infusion of angiotensin II to hyperlipidemic mice increases atherosclerosis and causes abdominal aortic aneurysms (AAAs), with their 2000 publication in The Journal of Clinical Investigation becoming highly influential (over 500 citations). Current research emphasizes mechanisms for sex differences in AAA formation and PCB-induced diabetes, particularly examining adipocyte aryl hydrocarbon receptors as mediators of inflammation and insulin resistance. Her work has been continuously NIH-funded since 1988. Analysis of Dr. Cassis's recent publications reveals a strong focus on sex differences in vascular pathologies, particularly abdominal aortic aneurysms. Her research integrates molecular mechanisms with physiological outcomes, emphasizing adipose tissue's role in cardiovascular disease. Recent work explores novel therapeutic targets including serotonin receptors and mitochondrial dynamics in aortic disease progression. The publications demonstrate a progression from foundational mechanistic work to translational applications, with increasing use of advanced techniques like single-cell transcriptomics. 1986 National Research Service Award Postdoctoral Fellowship 1991 IBM Supercomputer Competition, First Place 1992 Research Career Development Award, NIHLBI 2012 Women's Mentor of the Year, Council on Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association 2012 Mentor of the year, Center for Clinical and Translational Sciences, University of Kentucky 2012 Council for High Blood Pressure Research Harriett Dustan Award for Excellence in Hypertension Research Dr. Cassis has extensive experience administering major research programs including Director of a multidisciplinary graduate center focused on nutritional scientists, Chair of the Department of Nutritional Sciences, Chair of the Department of Molecular and Biomedical Pharmacology, Director of an NIH T32 on Nutrition and Oxidative Stress, and Director of the Phase II NIH Center of Biomedical Research Excellence on Obesity and Cardiovascular Diseases (COCVD). She has served in numerous leadership roles including as Project Director of a University of Kentucky Superfund Basic Science Research Program focused on polychlorinated biphenyls (PCBs). Dr. Cassis leads the Saha Cardiovascular Research Center and Saha Aortic Center at the University of Kentucky, where her laboratory investigates the intersection of metabolic and cardiovascular diseases. Her team combines molecular, cellular, and physiological approaches to study sex differences in vascular pathologies, with particular emphasis on abdominal aortic aneurysms and the role of adipose tissue in cardiovascular disease.

پروفایل رسمی دانشگاه

Michael S. Wolinمشاهده پروفایل

استاد

New York Medical CollegeUnited States

Michael S. Wolin, Ph.D., is a distinguished Professor of Physiology at the School of Medicine, New York Medical College (NYMC). With a career spanning several decades, Dr. Wolin has established himself as a leading researcher in vascular physiology, redox biology, and pulmonary hypertension. His work began with groundbreaking research on nitric oxide signaling as a postdoctoral fellow with Lou Ignarro at Tulane University, contributing to aspects of research that led to Ignarro's 1998 Nobel Prize in Physiology and Medicine. Dr. Wolin's research interests focus on oxidative stress signaling , pulmonary hypertension , vascular physiology , redox biology , nitric oxide signaling , and mitochondrial function . His NIH-funded laboratory at NYMC has made significant contributions to understanding how cellular regulatory systems—including mitochondrial function, oxidases, ROS metabolizing enzymes, and cellular redox control systems—function in physiological processes and pathophysiological conditions. His work has particularly advanced our understanding of oxygen sensing mechanisms, hypoxic pulmonary vasoconstriction, and the role of hydrogen peroxide as a signaling molecule. Dr. Wolin's recent publications (2019-2025) demonstrate continued research productivity with significant contributions to understanding placental development in maternal undernourishment, pulmonary vascular function, oxidative stress mechanisms in hypertension, and the role of various signaling molecules in cardiovascular disease progression. His work shows a consistent focus on the interplay between redox signaling, mitochondrial function, and vascular pathophysiology. Notable awards and honors include: Distinguished Scientist Award – American Chemical Society, Westchester Section (2010) Outstanding Faculty Award – Graduate Student Association of Basic Medical Sciences at NYMC (2009) Robert M. Berne – Distinguished Lectureship Awardee – American Physiological Society (2008) Merit Award – National Heart, Lung & Blood Institute, NIH (1995) Dr. Wolin has maintained significant editorial and service roles, including serving as Chair of the Integrative Vascular Physiology Pathology NIH Study Section (2021-2023), Consulting Editor for the American Journal of Physiology: Heart & Circulatory Physiology (2011-2018), and as a Fellow of the American Heart Association since 2001. His teaching responsibilities at NYMC include directing multiple physiology courses and mentoring graduate students through thesis research.

پروفایل رسمی دانشگاه

Ocean Setiaمشاهده پروفایل

پژوهشگر

Yale UniversityUnited States

Ocean Setia is a faculty member at Yale School of Medicine (Yale University), affiliated with the Dardik Laboratory for Vascular Biology and Therapeutics. He holds a medical degree (MBBS) from Sardar Patel Medical College (2016). His research focuses on vascular surgery innovations, diabetic kidney disease mechanisms, and surgical interventions for vascular pathologies. His work spans clinical studies on wound therapy, imaging techniques for vascular diagnostics, and mechanistic studies on endothelial cell biology and fibrosis. Key contributions include advancements in surgical techniques like mesenteric artery transposition and insights into sex hormone impacts on arteriovenous fistula maturation. He has published extensively in journals such as Science Advances , Journal of Vascular Surgery , and Annals of Vascular Surgery . Research interests emphasize translational applications of vascular biology, including machine learning algorithms for occlusion detection and regenerative therapies using stem cells. His articles highlight interdisciplinary approaches, combining surgical innovation with molecular mechanisms in diabetic complications. No scientific awards are explicitly mentioned, though his active publication record underscores scholarly engagement. Academically, he collaborates with clinicians and researchers like Britt Tonnessen, Jonathan Cardella, and Alan Dardik. His lab work involves preclinical models and human trials, focusing on improving outcomes for vascular diseases. No formal grants or student advisement roles are detailed in the provided texts.

پروفایل رسمی دانشگاه

Ali Nsairمشاهده پروفایل

استاد بالینی

University of California, Los AngelesUnited States

Ali Nsair, MD, is a Clinical Professor at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). He serves as the Director of the Heart Transplantation and Mechanical Circulatory Support Program at UCLA and is a key member of the Interventional and Structural Cardiology program. Nsair received his MD from the University of Alberta Faculty of Medicine in 2002, followed by Internal Medicine residency and Cardiology fellowship at the University of Alberta Hospital, with advanced training in Advanced Heart Failure and Interventional Cardiology at UCLA Medical Center and post-doctoral fellowship in regenerative therapies. His clinical focus spans heart transplantation, mechanical circulatory support, interventional cardiology, and sports cardiology.

پروفایل رسمی دانشگاه

Joel D. Trinityمشاهده پروفایل

دانشیار

University of UtahUnited States

Joel D. Trinity, PhD, is an Associate Professor in the Department of Internal Medicine at the University of Utah and holds adjunct appointments in the Department of Nutrition and Integrative Physiology and the Department of Physical Therapy & Athletic Training. He is affiliated with the Geriatrics Division and the Utah Vascular Research Laboratory (UVRL), where he has been a member since 2009. Education: PhD – The University of Texas at Austin MA – The University of Texas at Austin BA – Occidental College BA – University of California, Santa Cruz Postdoctoral Fellowship – University of Utah Advanced Fellowship – George E. Whalen VA Medical Center Research Focus: Dr. Trinity’s laboratory employs integrative in-vivo and in-vitro methodologies to investigate how aging and chronic diseases—particularly hypertension, heart failure, COPD, and peripheral artery disease—impair vascular function and blood-flow regulation. His work emphasizes the triad of neural control, oxidative stress, and endothelial signaling (especially nitric oxide) in determining vascular health across the lifespan. Publications Snapshot: From 2021-2025, Dr. Trinity has published extensively on human cardiovascular responses to exercise, vascular aging, and the vascular consequences of COVID-19. A recurring theme is the translational evaluation of passive leg movement as a non-invasive probe of endothelial function, with studies spanning young adults to older patients with multiple comorbidities. Funding & Collaborations: While specific grant numbers are not provided, the breadth of multi-center collaborations (e.g., RECOVER Consortium for long COVID) and continuous publication output indicate active federal and institutional funding. His laboratory hosts interdisciplinary trainees bridging geriatrics, exercise physiology, and vascular biology. Laboratory & Teams: Dr. Trinity conducts research within the Utah Vascular Research Laboratory (UVRL), leveraging state-of-the-art Doppler ultrasound, plethysmography, and metabolic assays to dissect vascular control mechanisms in human participants and murine models.

پروفایل رسمی دانشگاه

Helle F Jørgensenمشاهده پروفایل

دانشیار

University of CambridgeUnited Kingdom

Helle F Jørgensen is an Associate Professor at the University of Cambridge, based at the Victor Phillip Dahdaleh Heart and Lung Research Institute (VPD-HLRI). She is a Principal Investigator in the Cardiovascular and Respiratory Medicine (CaRM) section of the Department of Medicine and a key member of the Cambridge Cardiovascular Interdisciplinary Research Centre and the British Heart Foundation (BHF) Cambridge Centre of Excellence. Dr. Jørgensen earned her PhD in molecular biology from Aarhus University in 2000 under Professor Brian Clarke. Her postdoctoral training included research on DNA-methylation-binding factors with Professor Sir Adrian Bird at the University of Edinburgh and investigations into transcription factors and epigenetic mechanisms in embryonic stem cell maintenance with Professor Dame Amanda G Fisher at the London Institute of Medical Research. Her research focuses on vascular smooth muscle cell (VSMC) plasticity and heterogeneity in vascular health and disease. She has demonstrated that a small number of pre-existing VSMCs undergo extensive proliferative expansion to generate the majority of cells in atherosclerotic lesions, with similar clonal expansion observed in other vascular disease models. Using single-cell transcriptome profiling, her group has revealed substantial VSMC heterogeneity both in lesions and healthy arteries. This work has significant implications for understanding VSMC behavior and developing selective targeting strategies for disease-associated VSMCs. Her laboratory employs single-cell approaches, lineage tracing, and global epigenetic profiling to study how gene expression programs are regulated and impact phenotypic plasticity in genetic disease models and human tissue. They investigate how VSMCs contribute to atherosclerosis development, the disease underlying heart attack and stroke, with focus on how these cells downregulate their contractile phenotype in response to injury and inflammation. British Heart Foundation Senior Basic Science Research Fellow Dr. Jørgensen's work has important translational implications for cardiovascular medicine. Her research on VSMC heterogeneity and clonal expansion provides critical insights into atherosclerosis pathogenesis and identifies potential therapeutic targets. As part of the BHF Cambridge Centre of Excellence, her research contributes to the broader mission of improving cardiovascular and lung health worldwide through collaborative research across university, NHS, commercial, and charitable sectors. The Jorgensen Group operates within the Victor Phillip Dahdaleh Heart and Lung Research Institute, a state-of-the-art facility that brings together researchers and clinicians to advance understanding of cardiovascular and respiratory diseases. Her work bridges fundamental molecular mechanisms with clinical applications in vascular medicine.

پروفایل رسمی دانشگاه

Shu Q. Liuمشاهده پروفایل

استاد

Northwestern UniversityUnited States

Shu Q. Liu is a Professor of Biomedical Engineering at Northwestern University’s McCormick School of Engineering. His research focuses on cell protective engineering, particularly in cardiovascular and neuroprotective contexts, addressing ischemic disorders like heart attacks and strokes. He holds affiliations with the PhD Program in Interdisciplinary Biological Sciences. Education: Ph.D. in Bioengineering (University of California San Diego), M.S. and B.M. in Physiology (Medical School of Neimengu, China). Research Interests: Developing engineering strategies to understand and mitigate cell damage in ischemic conditions. Key areas include vascular smooth muscle cell behavior, biomaterials for arterial reconstruction, and liver-mediated organ protection mechanisms. Scientific Awards: Includes the 1994 Melville Medal (ASME), 1998 Established Investigator Award (American Heart Association), and multiple best paper awards. Advising & Grants: While specific grants are not listed, his work emphasizes translational research bridging engineering and medicine. Students advised are listed in his CV. Labs/Teams: Collaborations focus on biomaterials, cardiovascular engineering, and systems biology approaches to organ protection.

پروفایل رسمی دانشگاه

Harold A. Singerمشاهده پروفایل

استاد

Albany Medical CollegeUnited States

Dr. Harold A. Singer is a Professor and Chair in the Department of Molecular and Cellular Physiology at Albert Einstein College of Medicine. His research focuses on calcium signaling mechanisms in vascular smooth muscle cells, particularly the role of CaMKII isoforms in regulating gene transcription and vascular remodeling. Research spans vascular biology , signal transduction , and cardiovascular pathophysiology Key interests include CREB phosphorylation , CaMKIIδ function , and vessel injury responses His recent work examines CaMKII-endothelium interactions in re-endothelialization and angiogenesis . Grants from the NIH (R01 HL049426, R01 HL092510) support his investigations into vascular remodeling and disease mechanisms .

پروفایل رسمی دانشگاه